银河糖缺乏IgA1与转林受体1的溶解体介导的聚合与IgA脏病相关
Meijun Si1,2, Jingpeng Fu3,4, Mengting Fang1,2
1Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
在IgA脏病 (IgAN) 中,缺乏银糖的IgA1 (Gd-IgA1) 保留是由转移素受体1 (TfR1) 与介质细胞溶解体结合的介导. 这一过程导致聚合物形成,溶酶体功能障碍和炎症,提供了潜在的治疗点.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 在介质中缺少银糖的IgA1 (Gd-IgA1) 积累是IgA脏病 (IgAN) 的关键因素.
- 驱动Gd-IgA1保留和随后的损伤的精确细胞内机制尚未完全理解.
研究的目的:
- 为了阐明Gd-IgA1在介质细胞中的细胞内途径.
- 确定特定受体在Gd-IgA1吸收和保留中的作用.
- 根据Gd-IgA1处理,探索IgAN的潜在治疗点.
主要方法:
- 在培养的人类中细胞中研究了Gd-IgA1吸收和溶酶体命运.
- 使用了转移素受体1 (TfR1) 表达变化的小鼠模型.
- 从IGAN患者的脏活检中分析IgA1聚合物局部化.
主要成果:
- 转激素受体1 (TfR1) 调解了Gd-IgA1的吸收到中细胞溶解体中.
- 在溶解体内,Gd-IgA1形成了不可消化的聚合物,损害了溶解体功能,并启动了炎症反应.
- 过度表达TfR1增加了小鼠的Gd-IgA1溶酶体积累,而TfR1倒置则减少了它.
- 在IGAN患者活检中,IgA1聚合物和TfR1被发现在溶酶体内共定位.
结论:
- 通过TfR1进行受体介导的内细胞分裂是Gd-IgA1在介质细胞中的保留的关键机制.
- Gd-IgA1聚合物的溶酶体积累会在IgAN中触发致病过程.
- 针对TfR1-介导的Gd-IgA1吸收,为IgAN提供了一个潜在的治疗策略.
更多相关视频
11:10Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
05:39Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
Published on: July 8, 2020
相关概念视频
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
The Early Endosome: Endocytosis of Transferrin
Lysosomal Hydrolases
Glucose Absorption Into the Small Intestine
